Flaviviruses including dengue, West Nile, yellow fever, and Japanese encephalitis viruses, pose significant threats as emerging diseases and potential bioterror agents. Despite the considerable impact of flavivirus infection on world-wide health, no antiviral therapies are available, and existing flavivirus vaccines are of limited utility. The long-term goal of this project is to develop antiviral therapeutics based on structural and biochemical information regarding the flavivirus replicase complex. Since replicase complexes are absolutely required for virus replication, knowledge of their structures and mechanisms should identify potential targets for therapeutics and suggest strategies for intervention against threats from these infectious diseases. The flavivirus replicase complex, consisting of a virally-encoded RNA polymerase and helicase as well as other viral and unidentified cellular proteins, is responsible for copying the viral genome. During replication, 5'-RNA capping of the nascent strand occurs along with RNA synthesis. The viral NS5 polymerase has both RNA-dependent RNA polymerase (RdRp) and 5'-RNA methyltransferase (MTase) activities within a single polypeptide, indicating that the RNA synthesis and capping processes may be coupled. Little is known as to whether or how the two activities are coordinated during replication, largely due to a lack of detailed structural information about the full-length polymerase.
In Aim 1, the interactions of the RdRp and MTase domains within dengue virus NS5 and the conformational changes that occur therein during the polymerase and methylation reactions, will be determined by small-angle X-ray scattering in solution (Aim 1a). The resulting NS5 model will be tested in recombinant protein and in the infectious virus using site-directed mutagenesis (Aim 1b).
In Aim 2, interactions of the full-length NS5 polymerase with RNA will be investigated. A 'dual'substrate that can bind simultaneously to both the RdRp and MTase domains will be designed and tested for its binding to the full- length NS5.
In Aim 3, the X-ray crystal structures of the full-length dengue NS5 polymerase and its RNA complexes at different steps along the catalytic pathway will be determined. The combined structural, biochemical, and virological studies will help elucidate the mechanisms for RNA synthesis and its potential coordination with capping reactions in the NS5 polymerase.

Public Health Relevance

Flaviviruses such as dengue virus pose significant threats as emerging diseases and potential bioterror agents. We will perform integrated structural, biochemical, and virological studies on the dengue virus polymerase that carries out viral genome replication processes. The results of our studies will lay the foundation for developing antiviral therapeutics to treat these currently untreatable and often deadly infectious diseases.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI087856-04
Application #
8617790
Study Section
Virology - A Study Section (VIRA)
Program Officer
Cassetti, Cristina
Project Start
2011-03-10
Project End
2016-02-29
Budget Start
2014-03-01
Budget End
2015-02-28
Support Year
4
Fiscal Year
2014
Total Cost
$382,750
Indirect Cost
$106,000
Name
University of Texas Medical Br Galveston
Department
Biochemistry
Type
Schools of Medicine
DUNS #
800771149
City
Galveston
State
TX
Country
United States
Zip Code
77555
Bujalowski, Paul J; Bujalowski, Wlodzimierz; Choi, Kyung H (2017) Interactions between the Dengue Virus Polymerase NS5 and Stem-Loop A. J Virol 91:
Liu, Yang; Liu, Jianying; Du, Senyan et al. (2017) Evolutionary enhancement of Zika virus infectivity in Aedes aegypti mosquitoes. Nature 545:482-486
Teramoto, Tadahisa; Balasubramanian, Anuradha; Choi, Kyung H et al. (2017) Serotype-specific interactions among functional domains of dengue virus 2 nonstructural proteins (NS) 5 and NS3 are crucial for viral RNA replication. J Biol Chem 292:9465-9479
Xie, Xuping; Yang, Yujiao; Muruato, Antonio E et al. (2017) Understanding Zika Virus Stability and Developing a Chimeric Vaccine through Functional Analysis. MBio 8:
Wong, Susan J; Furuya, Andrea; Zou, Jing et al. (2017) A Multiplex Microsphere Immunoassay for Zika Virus Diagnosis. EBioMedicine 16:136-140
Shan, Chao; Xie, Xuping; Muruato, Antonio E et al. (2016) An Infectious cDNA Clone of Zika Virus to Study Viral Virulence, Mosquito Transmission, and Antiviral Inhibitors. Cell Host Microbe 19:891-900
Schein, Catherine H; Rowold, Diane; Choi, Kyung H (2016) Allosteric inhibitors of Coxsackie virus A24 RNA polymerase. Bioorg Med Chem 24:570-7
Deng, Yong-Qiang; Zhang, Na-Na; Li, Chun-Feng et al. (2016) Adenosine Analog NITD008 Is a Potent Inhibitor of Zika Virus. Open Forum Infect Dis 3:ofw175
Akiyama, Benjamin M; Laurence, Hannah M; Massey, Aaron R et al. (2016) Zika virus produces noncoding RNAs using a multi-pseudoknot structure that confounds a cellular exonuclease. Science 354:1148-1152
Klema, Valerie J; Ye, Mengyi; Hindupur, Aditya et al. (2016) Dengue Virus Nonstructural Protein 5 (NS5) Assembles into a Dimer with a Unique Methyltransferase and Polymerase Interface. PLoS Pathog 12:e1005451

Showing the most recent 10 out of 21 publications